Abstract
Tadalafil, a type 5 phosphodiesterase inhibitor, is a new and effective therapy for erectile dysfunction. It has unique pharmacokinetic properties in its drug class, which also includes sildenafil and vardenafil. It is also well tolerated with few side-effects, and can be used in difficult patients such as neuropaths or diabetics.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Carbolines / adverse effects*
-
Carbolines / classification
-
Carbolines / pharmacokinetics
-
Carbolines / therapeutic use*
-
Diabetes Complications
-
Endothelium, Vascular / drug effects
-
Endothelium, Vascular / pathology
-
Erectile Dysfunction / complications
-
Erectile Dysfunction / drug therapy*
-
Half-Life
-
Humans
-
Male
-
Nervous System Diseases / complications
-
Penile Erection / drug effects
-
Phosphodiesterase Inhibitors / adverse effects
-
Phosphodiesterase Inhibitors / classification
-
Phosphodiesterase Inhibitors / pharmacokinetics
-
Phosphodiesterase Inhibitors / therapeutic use*
-
Tadalafil
-
Vasodilator Agents / adverse effects
-
Vasodilator Agents / classification
-
Vasodilator Agents / pharmacokinetics
-
Vasodilator Agents / therapeutic use*
Substances
-
Carbolines
-
Phosphodiesterase Inhibitors
-
Vasodilator Agents
-
Tadalafil